Current HAART regimens work by achieving maximal viral load suppression and increasing CD4+ T-cell (CD4+) counts[10], and have resulted in a substantial and dramatic decrease in acquired immunodeficiency syndrome (AIDS)-related opportunistic infections, morbidity, hospitalizations and deaths in HIV-infected children[8,11-15]. The gene discussed is CD4; the disease is Opportunistic infection.